CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study.
Zhang X, Zhou J, Zhu DD, Huang J, Sun JH, Li TF, Shi CS, Sun ZC, Hou QM, Peng ZY, Yu WQ, Ji JS, Gu WJ, Zhou GH, Xie XX, Guo XH, Cao GH, Yu ZH, Xu HH, Fang J, Ying SH, Hu WH, Ji WB, Han J, Wu X, Zheng JP, Luo J, Chen YT, Hu TY, Li L, Hu HJ, Du HJ, Shao GL.
Zhang X, et al. Among authors: zhou j, zhou gh.
Clin Transl Oncol. 2019 Feb;21(2):167-177. doi: 10.1007/s12094-018-1902-8. Epub 2018 Jul 12.
Clin Transl Oncol. 2019.
PMID: 30003530
Clinical Trial.